Viewing Study NCT03896269


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-29 @ 4:02 AM
Study NCT ID: NCT03896269
Status: RECRUITING
Last Update Posted: 2025-10-23
First Post: 2019-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module